The Freestyle Libre 2, Abbott’s Flash Glucose Monitoring (FGM) device has recently been approved in the USA as an integrated continuous glucose monitor (iCGM). The new device will use Bluetooth technology to alert the user of high and low blood sugars which CGM monitors have been able to do. Reports are that it is the same cost in USD and offers better accuracy than the Freestyle Libre device currently available in Canada.
Read more at: https://diatribe.org/freestyle-libre-2-cleared-fda-icgm
